BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9430355)

  • 21. Receptor-mediated transport of oligodeoxynucleotides into hepatic cells.
    Reinis M; Damková M; Korec E
    J Virol Methods; 1993 Apr; 42(1):99-105. PubMed ID: 7686560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of antiviral drugs by coupling with protein carriers.
    Fiume L; Busi C; Mattioli A
    FEBS Lett; 1983 Mar; 153(1):6-10. PubMed ID: 6186534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of Ectromelia virus DNA synthesis in hepatocytes by adenine-9-beta-D-arabinofuranoside (ara-A) and adenine-9-beta-D-arabinofuranoside 5'-monophosphate (ara-AMP) conjugated to asialofetuin.
    Fiume L; Mattioli A; Busi C; Balboni PG; Barbanti-Brodano G; De Vries J; Altmann R; Wieland T
    FEBS Lett; 1980 Jul; 116(2):185-8. PubMed ID: 6157565
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug targeting in antiviral chemotherapy. A chemically stable conjugate of 9-beta-D-arabinofuranosyl-adenine 5'-monophosphate with lactosaminated albumin accomplishes a selective delivery of the drug to liver cells.
    Fiume L; Bassi B; Busi C; Mattioli A; Spinosa G
    Biochem Pharmacol; 1986 Mar; 35(6):967-72. PubMed ID: 2420334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenine arabinoside monophosphate and acyclovir monophosphate coupled to lactosaminated albumin reduce woodchuck hepatitis virus viremia at doses lower than do the unconjugated drugs.
    Ponzetto A; Fiume L; Forzani B; Song SY; Busi C; Mattioli A; Spinelli C; Marinelli M; Smedile A; Chiaberge E
    Hepatology; 1991 Jul; 14(1):16-24. PubMed ID: 1712338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjugates of adenine 9-alpha-D-arabinofuranoside monophosphate (ara-AMP) with lactosaminated homologous albumin are not immunogenic in the mouse.
    Fiume L; Mattioli A; Busi C; Spinosa G; Wieland T
    Experientia; 1982 Sep; 38(9):1087-9. PubMed ID: 6182024
    [No Abstract]   [Full Text] [Related]  

  • 27. Conjugation of adenine arabinoside 5'-monophosphate to arabinogalactan: synthesis, characterization, and antiviral activity.
    Enriquez PM; Jung C; Josephson L; Tennant BC
    Bioconjug Chem; 1995; 6(2):195-202. PubMed ID: 7541249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and rat.
    Fiume L; Busi C; Preti P; Spinosa G
    Cancer Drug Deliv; 1987; 4(3):145-50. PubMed ID: 2453263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary clinic observation on the inhibition of HBV by receptor-targeted drug L-HSA-AraAMP].
    Wang H; Zhang L; Wang X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):12-4. PubMed ID: 12515162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of [3H]thymidine incorporation into DNA of rat regenerating liver by 2',2'-difluorodeoxycytidine coupled to lactosaminated poly-L-lysine.
    Di Stefano G; Busi C; Mattioli A; Derenzini M; Trerè D; Fiume L
    Biochem Pharmacol; 1999 Apr; 57(7):793-9. PubMed ID: 10075085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas.
    Di Stefano G; Busi C; Derenzini M; Trerè D; Fiume L
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):173-7. PubMed ID: 9675653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin.
    Fiume L; Bassi B; Busi C; Mattioli A; Wieland T
    Experientia; 1985 Oct; 41(10):1326-8. PubMed ID: 2412878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arabinogalactan for hepatic drug delivery.
    Groman EV; Enriquez PM; Jung C; Josephson L
    Bioconjug Chem; 1994; 5(6):547-56. PubMed ID: 7533005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor.
    Dini L; Autuori F; Lentini A; Oliverio S; Piacentini M
    FEBS Lett; 1992 Jan; 296(2):174-8. PubMed ID: 1370803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted protection of hepatocytes from galactosamine toxicity in vivo.
    Keegan-Rogers V; Wu GY
    Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin.
    Simpson DL; Cawley DB; Herschman HR
    Cell; 1982 Jun; 29(2):469-73. PubMed ID: 6180832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose-independent manner.
    Bennatt DJ; Ling YY; McAbee DD
    Biochemistry; 1997 Jul; 36(27):8367-76. PubMed ID: 9204884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.
    Cawley DB; Simpson DL; Herschman HR
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3383-7. PubMed ID: 6167984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and physicochemical characteristics of a liver-targeted conjugate of fluorodeoxyuridine monophosphate with lactosaminated human albumin.
    Di Stefano G; Tubaro M; Lanza M; Boga C; Fiume L; Traldi P
    Rapid Commun Mass Spectrom; 2003; 17(22):2503-7. PubMed ID: 14608620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
    Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
    Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.